Merck is investing about $470 million in Ireland to increase its membrane and filtering production capabilities.
The company will expand membrane manufacturing capacity at its existing Carrigtwohill factory and construct a new manufacturing facility at Blarney Business Park, in Cork, Ireland.
Merck expects to add more than 370 jobs by the end of 2027 as a result of this expansion and the development of a new production facility.
Merck is expected to invest roughly US $157 million in the Blarney Business Park to establish a new filtration manufacturing facility.
The upcoming facility is expected to boost the company's global manufacturing capacity and provide clients with both traditional and novel therapies once it is fully operational.
It will also spend more than US $303 million to expand the Carrigtwohill factory, which will include the addition of a facility for immersion casting membranes.
Also, it will invest more than US $303 million in the expansion of the Carrigtwohill facility, which includes adding a facility for the manufacturing of immersion casting of membranes.
Novel and gene therapies, as well as applications such as viral sterilization, will be supported by the membranes.